In a report released today, Eric Joseph from J.P. Morgan maintained a Hold rating on Verve Therapeutics (VERV – Research Report), with a price ...

BioNJ is proud to present its 15th Annual BioPartnering Conference on Tuesday, May 13, at the Liberty Science Center in ...

Bluebird has reaffirmed its support for a proposed acquisition after Ayrmid failed to deliver a binding offer by the extended ...

With another JP Morgan in the rearview mirror ... Andrew Obershain, CEO of bluebird bio, said as much on stage. A year before the FDA approved his company’s gene therapy for sickle cell ...

The JP Morgan Healthcare Conference remains one of ... Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals.

Sports hero Marion Hollins developed Pasatiempo Golf Course, but had a fascinating career before she became a Santa Cruzan,” ...

Robin Sharma, the self-help guru and author of The 5 a.m. Club, is up—“4 a.m. is the new 5 a.m.” he told GQ recently—for a ...

U.S. stock futures point lower as China vows to retaliate against efforts to isolate the country, and a top Fed official says ...

The Titanic sank on April 15, 1912. Here are some facts you might not have known about the ship, its crew, and the discovery of the ship.

J.P. Morgan Asset Management today announced that Geng Ngarmboonanant will join the firm's Multi-Asset Solutions business as a managing director specializing in global business and investment strategy ...

Geng Ngarmboonanant has joined J.P. Morgan Asset Management as managing director-global business and investment strategy in ...

Investing.com -- JP Morgan downgraded Sea Ltd (NYSE:SE) to “Neutral” from “Overweight,” flagging heightened macroeconomic headwinds and an uncertain outlook for the region’s internet ...